These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. CT and functional respiratory tests. Evaluation of efficacy of bronchodilator therapy in chronic obstructive pulmonary disease (COPD). Costantini AM; Sallustio G; Misciasci T; Corbo GM; Valente S; Pirronti T; Marano P Radiol Med; 2004; 108(1-2):17-27. PubMed ID: 15269687 [TBL] [Abstract][Full Text] [Related]
44. Assessment of emphysema in COPD: a functional and radiologic study. Cerveri I; Dore R; Corsico A; Zoia MC; Pellegrino R; Brusasco V; Pozzi E Chest; 2004 May; 125(5):1714-8. PubMed ID: 15136381 [TBL] [Abstract][Full Text] [Related]
45. The objective evaluation of obstructive pulmonary diseases with spirometry. Ozkaya S; Dirican A; Tuna T Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884 [TBL] [Abstract][Full Text] [Related]
46. [The role of lung volume measurements by plethysmography in the follow-up of asthma in children]. Labbé G; Merlin E; Kauffman C; Fauquert JL; Héraud MC; Labbé A Rev Mal Respir; 2010; 27(1):42-8. PubMed ID: 20146951 [TBL] [Abstract][Full Text] [Related]
47. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [TBL] [Abstract][Full Text] [Related]
48. The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease. French A; Balfe D; Mirocha JM; Falk JA; Mosenifar Z Int J Chron Obstruct Pulmon Dis; 2015; 10():1305-12. PubMed ID: 26203237 [TBL] [Abstract][Full Text] [Related]
49. Effect of surgical lung volume reduction on respiratory muscle function in pulmonary emphysema. Teschler H; Stamatis G; el-Raouf Farhat AA; Meyer FJ; Costabel U; Konietzko N Eur Respir J; 1996 Sep; 9(9):1779-84. PubMed ID: 8880091 [TBL] [Abstract][Full Text] [Related]
50. Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients. Gatta D; Fredi M; Aliprandi G; Pini L; Tantucci C Int J Chron Obstruct Pulmon Dis; 2013; 8():169-73. PubMed ID: 23569371 [TBL] [Abstract][Full Text] [Related]
51. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study. Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005 [TBL] [Abstract][Full Text] [Related]
52. The Impact of Positive Expiratory Pressure Therapy on Hyperinflation in Patients With COPD. de Macedo JRFF; Conceiçãodos Dos Santos ED; Reychler G; Poncin W Respir Care; 2024 Feb; 69(3):366-375. PubMed ID: 38416659 [TBL] [Abstract][Full Text] [Related]
53. Diagnostic role of residual volume in paediatric patients with chronic symptoms of the lower airways. Walamies MA Clin Physiol; 1998 Jan; 18(1):49-54. PubMed ID: 9545620 [TBL] [Abstract][Full Text] [Related]
54. Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD. Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF Respir Physiol Neurobiol; 2010 Aug; 173(1):58-63. PubMed ID: 20601207 [TBL] [Abstract][Full Text] [Related]
55. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease. Broseghini C; Testi R; Polese G; Tosatto R; Rossi A Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852 [TBL] [Abstract][Full Text] [Related]
56. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea. Diba C; King GG; Berend N; Salome CM Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091 [TBL] [Abstract][Full Text] [Related]
57. Lobar distribution of non-emphysematous gas trapping and lung hyperinflation in chronic obstructive pulmonary disease. Shima H; Tanabe N; Sato S; Oguma T; Kubo T; Kozawa S; Koizumi K; Watanabe A; Sato A; Togashi K; Hirai T Respir Investig; 2020 Jul; 58(4):246-254. PubMed ID: 32085990 [TBL] [Abstract][Full Text] [Related]
58. Bronchodilator responsiveness in patients with COPD. Tashkin DP; Celli B; Decramer M; Liu D; Burkhart D; Cassino C; Kesten S Eur Respir J; 2008 Apr; 31(4):742-50. PubMed ID: 18256071 [TBL] [Abstract][Full Text] [Related]
59. Use of forced inspiratory vital capacity to identify bronchodilator reversibility in obstructive lung disease. Biring MS; Madison S; Mohsenifar Z J Asthma; 2001 Sep; 38(6):495-500. PubMed ID: 11642416 [TBL] [Abstract][Full Text] [Related]
60. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. O'Donnell DE; Lam M; Webb KA Am J Respir Crit Care Med; 1999 Aug; 160(2):542-9. PubMed ID: 10430726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]